$3 Dollar Stocks To Buy Now
Discover investment opportunities in $3 Dollar Stocks To Buy Now using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in $3 Dollar Stocks To Buy Now using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in $3 Dollar Stocks To Buy Now using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in $3 Dollar Stocks To Buy Now using our Smart AI Filter.
7 stocks found for "$3 Dollar Stocks To Buy Now"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
1.47 | ±85.6% | -6.9 | 0.00% | |||
1.46 | ±96.7% | -13.1 | 0.00% | |||
0.50 | ±100.0% | — | 0.00% | |||
0.86 | ±55.0% | 41.8 | 0.00% | |||
1.69 | ±100.0% | -5.9 | 0.00% | |||
2.23 | ±99.6% | 441.5 | 0.00% | |||
1.72 | ±100.0% | -11.8 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Read moreFresh Vine Wine Inc (AMEX:VINE) is trading significantly higher Wednesday after the company announced a partnership with CRAVE American Kitchen & Sushi Bar. The Fresh Vine Wine premium lower carb, lower sugar and calorie varietals are to be paired with the American eclectic menu offered by CRAVE.
Read moreQ: How does Sirius XM Holdings Inc. (SIRI) generate revenue, considering its low-cost stock price?
A: Sirius XM Holdings Inc. (SIRI) primarily generates revenue through satellite radio subscriptions and advertising sales across its platforms. Its competitive edge lies in its exclusive content and contracts with major automotive manufacturers, which integrate its services into vehicles.
Q: What factors influence the stock performance of Gold Standard Ventures Corp. (GSV)?
A: Gold Standard Ventures Corp. (GSV) stock performance is influenced by gold market prices, exploration results, and the company's ability to raise funds for further development. Geopolitical events and economic factors impacting gold demand also play significant roles.
Q: Is Zomedica Corp. (ZOM) considered a growth stock in the veterinary healthcare sector?
A: Zomedica Corp. (ZOM) aims to capture growth opportunities in the veterinary healthcare sector with its diagnostic platforms. However, as a small-cap, early-stage company, its growth potential is tempered by limited revenue and high competitive pressures.
Q: What are the income potential and dividend prospects of MannKind Corporation (MNKD)?
A: MannKind Corporation (MNKD) focuses on biopharmaceuticals, specifically inhalable insulin products, and does not currently offer dividends. Investors may look at potential future profitability and product acceptance for income prospects, though risks are high.
Q: What sector-specific risks are associated with investing in Ring Energy, Inc. (REI)?
A: Ring Energy, Inc. (REI) faces sector-specific risks such as fluctuating oil and gas prices, regulatory changes, and operational challenges in shale drilling. Economic conditions impacting energy demand may also affect performance.
Q: How does Edesa Biotech, Inc. (EDSA) position itself in the biotechnology market?
A: Edesa Biotech, Inc. (EDSA) positions itself in the biotechnology market by focusing on dermatological and inflammatory conditions. Its growth hinges on successful clinical trials and regulatory approval, with high volatility typical of biotech investments.